Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 50%

Thread starter U.S. News
Start date Wednesday at 12:22 PM

U.S. News

Guest

Wednesday at 12:22 PM

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 50%

Prefix: N/A

Forum: USA News

Start date: Wednesday at 12:22 PM

Last reply date: Wednesday at 12:22 PM

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Wednesday at 12:22 PM

Replies: 0

Views: 14

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search